Attached files
| file | filename |
|---|---|
| EX-32.2 - EX-32.2 - Aadi Bioscience, Inc. | arpo-ex322_6.htm |
| EX-32.1 - EX-32.1 - Aadi Bioscience, Inc. | arpo-ex321_7.htm |
| EX-31.2 - EX-31.2 - Aadi Bioscience, Inc. | arpo-ex312_8.htm |
| EX-31.1 - EX-31.1 - Aadi Bioscience, Inc. | arpo-ex311_9.htm |
| EX-10.15 - EX-10.15 - Aadi Bioscience, Inc. | arpo-ex1015_878.htm |
| 10-K - 10-K - Aadi Bioscience, Inc. | arpo-10k_20171231.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the following Registration Statements:
|
|
(1) |
Registration Statement (Form S-8 No. 333-220057) pertaining to the Aerpio Therapeutics, Inc. 2011 Equity Incentive Plan, Aerpio Pharmaceuticals, Inc. 2017 Stock Option and Incentive Plan, and Aerpio Pharmaceuticals, Inc. 2017 Employee Stock Purchase Plan, and |
|
|
(2) |
Registration Statement (Form S-3 No. 333-223113) of Aerpio Pharmaceuticals, Inc., |
of our report dated March 15, 2018, with respect to the consolidated financial statements of Aerpio Pharmaceuticals, Inc., included in this Annual Report (Form 10-K) for the year ended December 31, 2017.
/s/ Ernst & Young LLP
Cincinnati, Ohio
March 15, 2018